ZAZA, ANTONIO

ZAZA, ANTONIO  

DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE  

Mostra records
Risultati 1 - 20 di 89 (tempo di esecuzione: 0.019 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Early consequences of the phospholamban mutation PLN-R14del+/− in a transgenic mouse model 01 - Articolo su rivista 2024 Maniezzi C.Eskandr M.Florindi C.Sacco E.Pasquale V.Lodola F.Zaza A. +
Kinematics but not kinetics alterations to single-leg drop jump movements following a subject-tailored fatiguing protocol suggest an increased risk of ACL injury 01 - Articolo su rivista 2024 Nardon, MauroFerri, UmbertoCaffi, GiovanniBartesaghi, ManuelaPerin, CeciliaZaza, AntonioAlessandro, Cristiano
Selective SERCA2a activator as a candidate for chronic heart failure therapy 01 - Articolo su rivista 2024 Arici, MartinaRonchi, CarlottaTorre, EleonoraLuraghi, AndreaPeri, FrancescoZaza, AntonioRocchetti, Marcella +
Early consequences of the phospholamban mutation PLN-R14del+/- in a transgenic mouse model 99 - Altro 2023 Maniezzi, CEskandr, MFlorindi, CSacco, EPasquale, VLodola, FZaza, A +
Exploring the pathophysiological role of the PLN-R14del mutation in a novel heterozygous mouse model of dilated cardiomyopathy 02 - Intervento a convegno 2023 Lodola, FManiezzi, CEskandr, MFlorindi, CZaza, A +
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2 01 - Articolo su rivista 2023 Zaza, AntonioCrotti, LiaSala, Luca +
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function 01 - Articolo su rivista 2023 Arici M.Torre E.Luraghi A.Ronchi C.Peri F.Rocchetti M.Zaza A. +
Characterization of the PLN-R14Del mutation in hiPSC-derived cardiomyocytes 02 - Intervento a convegno 2022 Badone, BLodola, FManiezzi, CMartone, DZaza, A +
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure 01 - Articolo su rivista 2022 Andrea LuraghiMartina AriciEleonora TorreCarlotta RonchiAlessio RomerioAntonio ZazaMarcella RocchettiFrancesco Peri +
Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function 02 - Intervento a convegno 2022 Arici, MTorre, ELuraghi, ARonchi, CPeri, FRocchetti, MZaza, A +
Mobile Anchors 01 - Articolo su rivista 2022 Zaza, Antonio
SERCA2a gain of function in patient-derived R14Del hiPSC-CMs 01 - Articolo su rivista 2022 Badone B.Ronchi C.Lodola F.Maniezzi C.Eskandr M.Zaza A. +
Characterization of the pln p.Arg14del mutation in human induced pluripotent stem cell-derived cardiomyocytes 01 - Articolo su rivista 2021 Badone B.Ronchi C.Lodola F.Zaza A. +
Edward Carmeliet (1930-2021) - Channelling scientific curiosity: A tribute from the ESC Working Group on Cardiac Cellular Electrophysiology 01 - Articolo su rivista 2021 Zaza A. +
ESC working group on cardiac cellular electrophysiology position paper: Relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research 01 - Articolo su rivista 2021 Zaza A. +
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 01 - Articolo su rivista 2021 Sala, LucaRocchetti, MarcellaCrotti, LiaTorre, EleonoraZaza, Antonio +
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 01 - Articolo su rivista 2021 Ronchi, CarlottaBernardi, JoyceBadone, BeatriceRocchetti, MarcellaCrotti, LiaZaza, Antonio +
Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome 01 - Articolo su rivista 2021 Zaza A.Lodola F.
The long-lasting istaroxime metabolite PST3093 stimulates SERCA2a and reverses disease-induced changes in cardiac function 02 - Intervento a convegno 2021 Arici, MFerrandi, MTorre, ELuraghi, ARonchi, CPeri, FRocchetti, MZaza, A +
2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia 01 - Articolo su rivista 2020 Zaza A. +